| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/17/2008 | WO2008008513A2 Combination treatments |
| 01/17/2008 | WO2008008507A2 Methods of treatment of diabetes |
| 01/17/2008 | WO2008007932A1 Chitosan complex containing ph sensitive imidazole group and preparation method thereof |
| 01/17/2008 | WO2008007796A1 Controlled-release drug preparation and method for producing the same |
| 01/17/2008 | WO2008007654A1 Prophylactic and/or therapeutic agent for aneurysm |
| 01/17/2008 | WO2008007426A1 Analgesic agent |
| 01/17/2008 | WO2008007091A1 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 01/17/2008 | WO2008006895A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 01/17/2008 | WO2007137164A3 Co-therapy for the treatment of epilepsy and related disorders |
| 01/17/2008 | WO2007067341A3 Compositions and methods for increasing insulin sensitivity |
| 01/17/2008 | WO2005046571A3 Lactoferrin as an adjuvant in cancer vaccines |
| 01/17/2008 | WO2004100899A3 Use of secretin in treatments of disorders associated with the amygdala |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | WO2002053187A3 Methods and transdermal compositions for pain relief |
| 01/17/2008 | US20080015332 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2008 | US20080015261 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 01/17/2008 | US20080015249 Cancer treatment compositions and method using natural plant essential oils |
| 01/17/2008 | US20080014623 Nutrient absorption enhancing compositions and methods |
| 01/17/2008 | US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 01/17/2008 | US20080014577 Oncolytic viruses as phenotyping agents for neoplasms |
| 01/17/2008 | US20080014291 Process for the Production of Multi-Component Mineral Substance Preparations |
| 01/17/2008 | US20080014266 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014195 Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases |
| 01/17/2008 | US20080014175 Methods and Compositions for Viral Enhancement of Cell Killing |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | US20080014172 Use of Il-17 in the Treatment of Fertility-Related Disorders |
| 01/17/2008 | CA2658222A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using .gamma. .delta. t cell activators |
| 01/16/2008 | EP1878800A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight |
| 01/16/2008 | EP1878799A2 Methods of screening agents for activity using teleosts |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878444A1 Composition containing antidementia agent |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878431A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 01/16/2008 | EP1877095A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 01/16/2008 | EP1877093A2 Ascorbate binding peptides |
| 01/16/2008 | EP1877092A2 Delivery of tigecycline in the presence of warfarin |
| 01/16/2008 | EP1877091A1 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| 01/16/2008 | EP1877090A2 Trimeric ox40-immunoglobulin fusion protein and methods of use |
| 01/16/2008 | EP1877051A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION |
| 01/16/2008 | EP1711157A4 Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 01/16/2008 | EP1636585B1 Diaryl ureas with kinase inhibiting activity |
| 01/16/2008 | EP1351979B1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 01/16/2008 | EP1326639B1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1074268B1 Preventives or remedies for inflammatory intestinal diseases containing il-6 receptor antagonist antibodies |
| 01/16/2008 | CN201006187Y Five-element magnet therapy health belt |
| 01/16/2008 | CN101103984A Pharmaceutical compositions |
| 01/16/2008 | CN100361707C Method for treating gastrointestinal damage |
| 01/15/2008 | US7319933 Gene transcription assay method |
| 01/15/2008 | US7319170 Hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes; N-[(cyclohexylamino)carbonyl]-4-{3-[4-(4-fluorophenoxy)-2-propylphenoxy]propoxy}benzenesulfonamide |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2312839C Compositions for nasal administration |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/10/2008 | WO2008006052A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006051A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008006050A2 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008004231A1 Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 01/10/2008 | WO2008003667A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 01/10/2008 | WO2007122382A3 Lycopene for the treatment of metabolic dysfunction |
| 01/10/2008 | WO2007090862A3 Neutral sphingomyelinase-3 and its use |
| 01/10/2008 | WO2007081910A3 Compositions and methods of treatment using modulators of motonueron diseases |
| 01/10/2008 | WO2007003330A3 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 01/10/2008 | WO2006135621A3 Method for renin-angiotensin-aldosterone system activation and control thereof |
| 01/10/2008 | WO2005042002A3 Treatment of rhematoid arthritis with flip antagonists |
| 01/10/2008 | WO2004108056A3 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease |
| 01/10/2008 | US20080009548 Ambroxol for the treatment of acute pain |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009434 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody |
| 01/10/2008 | US20080009068 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | CA2657093A1 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | CA2656135A1 Human il-4 muteins in cancer therapy |
| 01/10/2008 | CA2654666A1 Pharmaceutical compositions |
| 01/10/2008 | CA2650478A1 Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876237A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1875925A1 Preventive or remedy for bowel disease |
| 01/09/2008 | EP1875917A2 Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction |
| 01/09/2008 | EP1875916A2 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate |
| 01/09/2008 | EP1875915A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 01/09/2008 | EP1875909A2 Use of antagonists of PYY receptors for treating irritable bowel syndrome |
| 01/09/2008 | EP1875905A2 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances |